|
| 37665976 | Differential Induction of Interferon-Stimulated Genes by Cell-Based Versus Egg-Based Quadrivalent Influenza Vaccines in Children During the 2018-2019 Season. | J Infect Dis | 2024 |
| 36599411 | Relationship between Telework Experience and Presenteeism during COVID-19 Pandemic, United States, March-November 2020. | Emerg Infect Dis | 2023 |
| 37917142 | Work Attendance with Acute Respiratory Illness Before and During COVID-19 Pandemic, United States, 2018-2022. | Emerg Infect Dis | 2023 |
| 36949873 | Blood Inflammatory Biomarkers Differentiate Inpatient and Outpatient Coronavirus Disease 2019 From Influenza. | Open Forum Infect Dis | 2023 |
| 37316409 | Cost-effectiveness of an in-development adult-formulated pneumococcal vaccine in older US adults. | Vaccine | 2023 |
| 37246146 | Prior SARS-CoV-2 infection and COVID-19 vaccine effectiveness against outpatient illness during widespread circulation of SARS-CoV-2 Omicron variant, US Flu VE network. | Influenza Other Respir Viruses | 2023 |
| 37232430 | A Randomized Controlled Trial to Compare Immunogenicity to Cell-Based Versus Live-Attenuated Influenza Vaccines in Children. | J Pediatric Infect Dis Soc | 2023 |
| 37474406 | Vaccine effectiveness of recombinant and standard dose influenza vaccines against influenza related hospitalization using a retrospective test-negative design. | Vaccine | 2023 |
| 36960655 | Influenza Vaccine Effectiveness Among Children: 2011-2020. | Pediatrics | 2023 |
| 36694363 | Prevalence and Clinical Outcomes of Respiratory Syncytial Virus vs Influenza in Adults Hospitalized With Acute Respiratory Illness From a Prospective Multicenter Study. | Clin Infect Dis | 2023 |
| 36543682 | Factors associated with humoral immune response in older adults who received egg-free influenza vaccine. | Vaccine | 2023 |
| 36809982 | Vaccine effectiveness of recombinant and standard dose influenza vaccines against outpatient illness during 2018-2019 and 2019-2020 calculated using a retrospective test-negative design. | Hum Vaccin Immunother | 2023 |
| 36713477 | Effect of mild COVID-19 on health-related quality of life. | Brain Behav Immun Health | 2023 |
| 36536801 | Agent-based model of the impact of higher influenza vaccine efficacy on seasonal influenza burden. | Vaccine X | 2023 |
| 34320171 | Vaccine Effectiveness Against Acute Respiratory Illness Hospitalizations for Influenza-Associated Pneumonia During the 2015-2016 to 2017-2018 Seasons: US Hospitalized Adult Influenza Vaccine Effectiveness Network (HAIVEN). | Clin Infect Dis | 2022 |
| 35710506 | Vaccine-associated attenuation of subjective severity among outpatients with influenza. | Vaccine | 2022 |
| 35831685 | Cost-Effectiveness of Newly Recommended Pneumococcal Vaccination Strategies in Older Underserved Minority Adults in the USA. | Infect Dis Ther | 2022 |
| 35667912 | Estimating the burden of adult hospitalized RSV infection including special populations. | Vaccine | 2022 |
| 35684961 | Multiplex Detection of Antibody Landscapes to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)/Influenza/Common Human Coronaviruses Following Vaccination or Infection With SARS-CoV-2 and Influenza. | Clin Infect Dis | 2022 |
| 36336526 | Cost-effectiveness of revised US pneumococcal vaccination recommendations in underserved minority adults < 65-years-old. | Vaccine | 2022 |
| 36243591 | Trends in HPV vaccine administration and HPV vaccine coverage in children by race/ethnicity and socioeconomic status during the COVID-19 pandemic in an integrated health care system in California. | Vaccine | 2022 |
| 35996836 | Population-based hospitalization burden estimates for respiratory viruses, 2015-2019. | Influenza Other Respir Viruses | 2022 |
| 36366307 | Can a Two-Dose Influenza Vaccine Regimen Better Protect Older Adults? An Agent-Based Modeling Study. | Vaccines (Basel) | 2022 |
| 36100491 | Corrigendum to "Estimating the burden of adult hospitalized RSV infection including special populations". [Vaccine 40(31) (2022) 4121-4127]. | Vaccine | 2022 |
| 34859584 | Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults. | Influenza Other Respir Viruses | 2022 |
| 35271432 | Estimating the burden of adult hospitalized RSV infection using local and state data - methodology. | Hum Vaccin Immunother | 2022 |
| 35170231 | Vaccine effectiveness against COVID-19 among symptomatic persons aged â¿¥12 years with reported contact with COVID-19 cases, February-September 2021. | Influenza Other Respir Viruses | 2022 |
| 35321882 | SARS-CoV-2 Antibody Response Is Associated with Age and Body Mass Index in Convalescent Outpatients. | J Immunol | 2022 |
| 34643241 | Clinical Influenza Testing Practices in Hospitalized Children at United States Medical Centers, 2015-2018. | J Pediatric Infect Dis Soc | 2022 |
| 34750974 | Using capture-recapture methods to estimate influenza hospitalization incidence rates. | Influenza Other Respir Viruses | 2022 |
| 32505128 | Effects of Prior Season Vaccination on Current Season Vaccine Effectiveness in the United States Flu Vaccine Effectiveness Network, 2012-2013 Through 2017-2018. | Clin Infect Dis | 2021 |
| 33597114 | Influenza vaccination coverage among persons seeking outpatient medical care for acute respiratory illness in five states in the United States, 2011-2012 through 2018-2019. | Vaccine | 2021 |
| 33485643 | Comparison of local influenza vaccine effectiveness using two methods. | Vaccine | 2021 |
| 33726743 | Differences between Frequentist and Bayesian inference in routine surveillance for influenza vaccine effectiveness: a test-negative case-control study. | BMC Public Health | 2021 |
| 35024374 | Estimating the Impact of Low Influenza Activity in 2020 on Population Immunity and Future Influenza Seasons in the United States. | Open Forum Infect Dis | 2021 |
| 34498052 | Messenger RNA Vaccine Effectiveness Against Coronavirus Disease 2019 Among Symptomatic Outpatients Aged â¿¥16 Years in the United States, February-May 2021. | J Infect Dis | 2021 |
| 34790986 | SARS-CoV-2 Antibody Response is Associated with Age in Convalescent Outpatients. | medRxiv | 2021 |
| 34716041 | Agreement among sources of adult influenza vaccination in the age of immunization information systems. | Vaccine | 2021 |
| 34045104 | Is further research on adult pneumococcal vaccine uptake improvement programs worthwhile? ο value of information analysis. | Vaccine | 2021 |
| 33994240 | Sample size considerations for mid-season estimates from a large influenza vaccine effectiveness network in the United States. | Vaccine | 2021 |
| 34148625 | Higher-Valency Pneumococcal Conjugate Vaccines: An Exploratory Cost-Effectiveness Analysis in U.S. Seniors. | Am J Prev Med | 2021 |
| 33956782 | Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged â¿¥65 Years - United States, January-March 2021. | MMWR Morb Mortal Wkly Rep | 2021 |
| 34172329 | Helping patients with ethical concerns about COVID-19 vaccines in light of fetal cell lines used in some COVID-19 vaccines. | Vaccine | 2021 |
| 34167834 | Should older adult pneumococcal vaccination recommendations change due to decreased vaccination in children during the pandemic? A cost-effectiveness analysis. | Vaccine | 2021 |
| 32067049 | Relative and Absolute Effectiveness of High-Dose and Standard-Dose Influenza Vaccine Against Influenza-Related Hospitalization Among Older Adults-United States, 2015-2017. | Clin Infect Dis | 2021 |
| 32006430 | Effectiveness of Trivalent and Quadrivalent Inactivated Vaccines Against Influenza B in the United States, 2011-2012 to 2016-2017. | Clin Infect Dis | 2021 |
| 33462610 | Waning Vaccine Effectiveness Against Influenza-Associated Hospitalizations Among Adults, 2015-2016 to 2018-2019, United States Hospitalized Adult Influenza Vaccine Effectiveness Network. | Clin Infect Dis | 2021 |
| 33367650 | Effect of Antigenic Drift on Influenza Vaccine Effectiveness in the United States-2019-2020. | Clin Infect Dis | 2021 |
| 33079625 | Proposed clinical indicators for efficient screening and testing for COVID-19 infection using Classification and Regression Trees (CART) analysis. | Hum Vaccin Immunother | 2021 |
| 31401746 | Cost-Effectiveness of Pneumococcal Vaccination and Uptake Improvement Programs in Underserved and General Population Adults Aged⿿<⿿65 Years. | J Community Health | 2020 |